Publications by authors named "E d'Incan"

Claim this Profile
V
Venetoclax-based non-intensive induction followed by allogenic stem-cell transplantation in elderly acute myeloid leukemia patients with adverse cytogenetics.
Amel Soua, Julia Gilhodes, Alexandre Iat, Yosr Hicheri, Colombe Saillard, Evelyne D'Incan

Eur J Haematol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Azacitidine-venetoclax versus azacitidine salvage treatment for primary induction failure or first relapsed acute myeloid leukaemia patients.
C Petit, C Saillard, B Mohty, Y Hicheri, F Villetard, E D'Incan

Eur J Haematol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disseminated Scedosporium Invasive Fungal Infection in Critically ill Newly Diagnosed Acute Myeloid Leukemia Patient Complicated with Cerebritis.
Colombe Saillard, Magali Bisbal, Morgan Avenin, Pierre Lehmann, Antoine Sannini, Evelyne d'Incan

Mycopathologia· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Azacitidine Plus Venetoclax for the Treatment of Relapsed and Newly Diagnosed Acute Myeloid Leukemia Patients.
Sylvain Garciaz, Marie-Anne Hospital, Anne-Sophie Alary, Colombe Saillard, Yosr Hicheri, Evelyne D'Incan

Cancers (Basel)· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Herpesviridae in critically ill hematology patients: HHV-6 is associated with worse clinical outcome.
Frédéric Gonzalez, Samuel Beschmout, Laurent Chow-Chine, Magali Bisbal, Evelyne d'Incan

J Crit Care· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis